research and development news
Quintiles opens new European headquarters in the UK
October 12, 2011Research and Development Quintiles, research and development news
Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …
Contract research news in brief
October 5, 2011Research and Development research and development news
Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
Clinical research news in brief
September 8, 2011Research and Development research and development news
This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …
Eisai shares risk with novel trial funding approach
September 7, 2011Research and Development Eisai, clinical trials, research and development news
Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …
EMA should compare ‘like-for-like’ when assessing new drugs
September 7, 2011Research and Development EMA, clnical trials, research and development news
The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …
Lilly considering a stake in Turkish drugmaker
September 6, 2011Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news
Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …
Zonegran study could pave way for paediatric licence
September 2, 2011Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news
Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
Ex-Pfizer employees set up new business at Sandwich
September 1, 2011Research and Development Pfizer, Sandwich, The Research Network, research and development news
Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …
Clinical research news in brief
August 24, 2011Research and Development contract research news, research and development news
Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
UK research receives £800m funding boost
August 23, 2011Research and Development NIHR, UK research, UK science, research and development news
Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
Contract research news in brief
August 17, 2011Research and Development research and development news
Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …
Onyx Scientific bought by India’s Ipca Labs
August 16, 2011Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news
India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …
GSK Parkinson’s drug shows motor skills benefits
August 16, 2011Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news
GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …
